Evaluation Of The Effects Of Neptune Krill Oil On The Clinical Course Of Hyperlipidemia
| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 120 |
| Gender | Both Genders |
| Age Range | 30-44, 45-64, 65+ |
| Body Types | Obese, Overweight |
In hyperlipidemic subjects, supplementation of various doses of krill oil (1-3g) daily for 90 days resulted in remarkable reductions in LDL-C and improvements in HDL-C which outperformed the comparator of fish oil (3g daily).
| Effect | None |
| Trial Design | Cohort |
| Trial Length | 1-6 months |
| Number of Subjects | 115 |
| Gender | Both Genders |
| Age Range | 30-44, 45-64 |
| Body Types | Average |
This study noted comparable effects of krill oil (3,000mg, 543mg EPA+DHA) and fish oil (1,800mg, 864mg EPA+DHA) on serum biomarkers of lipid metabolism and oxidation over 7 weeks in otherwise healthy volunteers of both genders. Despite minimal changes in lipid parameters (most trending towards significance) there was a significant improvement in the HDL-C;Triglyceride ratio
Lipid peroxidation measures may be somewhat skewed as there was a Vitamin E content of the supplement, but no serum increase in Vitamin E was detected. A trend towards lower serum Vitamin E was noted.